FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1427884753> ?p ?o ?g. }

• W1427884753 endingPage "2232" @default.
• W1427884753 startingPage "2225" @default.
• W1427884753 abstract "We sought to verify whether the intravascular metabolism of chylomicron-like emulsion may predict the clinical evolution of patients with coronary artery disease (CAD) undergoing secondary prevention therapy of CAD.Case-control studies have suggested an association between impaired intravascular catabolism of triglyceride (TG)-rich lipoproteins and CAD. However, evidence is lacking with respect to the potential clinical relevance of this metabolic disorder in CAD patients.During a period of 4.5 +/- 0.9 years, we followed up 63 stable CAD patients (mean age 60 +/- 10 years) undergoing secondary prevention therapy (low-density lipoprotein cholesterol <100 mg/dl) in whom kinetic studies of the in vivo catabolism of chylomicron-like emulsions were performed. At enrollment into the study, fasting patients were injected intravenously with a chylomicron-like emulsion labeled with radioactive triglyceride (3H-TG) and cholesteryl esters (14C-CE) to evaluate the efficacy of intravascular TG lipolysis.At baseline, CAD patients displayed a diminished fractional clearance rate (FCR) for 3H-TG (-26%; p = 0.027), for 14C-CE (-37%; p = 0.015), and for delipidation index (DI) (-26%; p = 0.02) as compared with 35 control subjects. During follow-up of secondary prevention therapy, 33% of CAD patients (n = 21) presented with clinically refractory angina and aggravated coronary angiographic severity. The FCR for 3H-TG (-44%; p = 0.005) and DI (-41%; p = 0.006) in those patients with refractory angina was significantly lower than that observed in those with stable evolution. Moreover, in a Cox multivariate regression analysis, the presence of a DI less than the median value was an independent predictor of an unfavorable clinical evolution (adjusted hazard ratio 3.32; 95% confidence interval 1.21 to 9.14; p = 0.020).The current study establishes that delayed intravascular TG lipolysis is a strong and independent predictor of evolution to severe angina among patients undergoing secondary prevention therapy of CAD." @default.
• W1427884753 created "2016-06-24" @default.
• W1427884753 creator A5005583080 @default.
• W1427884753 creator A5008991847 @default.
• W1427884753 creator A5010448492 @default.
• W1427884753 creator A5016564415 @default.
• W1427884753 creator A5058128627 @default.
• W1427884753 creator A5058308987 @default.
• W1427884753 creator A5058932304 @default.
• W1427884753 creator A5073960839 @default.
• W1427884753 creator A5075845405 @default.
• W1427884753 creator A5086183706 @default.
• W1427884753 date "2004-06-01" @default.
• W1427884753 modified "2023-10-15" @default.
• W1427884753 title "Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment" @default.
• W1427884753 cites W1947778592 @default.
• W1427884753 cites W1981019535 @default.
• W1427884753 cites W1988814606 @default.
• W1427884753 cites W1991916817 @default.
• W1427884753 cites W2011468836 @default.
• W1427884753 cites W2013067322 @default.
• W1427884753 cites W2033917911 @default.
• W1427884753 cites W2037394642 @default.
• W1427884753 cites W2042894344 @default.
• W1427884753 cites W2054163601 @default.
• W1427884753 cites W2059234590 @default.
• W1427884753 cites W2066924253 @default.
• W1427884753 cites W2076996897 @default.
• W1427884753 cites W2077244492 @default.
• W1427884753 cites W2077677693 @default.
• W1427884753 cites W2097426078 @default.
• W1427884753 cites W2117219849 @default.
• W1427884753 cites W2140424137 @default.
• W1427884753 cites W2161500397 @default.
• W1427884753 cites W2182927870 @default.
• W1427884753 cites W2186855762 @default.
• W1427884753 cites W2271914866 @default.
• W1427884753 cites W2308889738 @default.
• W1427884753 doi "https://doi.org/10.1016/j.jacc.2003.11.065" @default.
• W1427884753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15193684" @default.
• W1427884753 hasPublicationYear "2004" @default.
• W1427884753 type Work @default.
• W1427884753 sameAs 1427884753 @default.
• W1427884753 citedByCount "31" @default.
• W1427884753 countsByYear W14278847532012 @default.
• W1427884753 countsByYear W14278847532013 @default.
• W1427884753 countsByYear W14278847532014 @default.
• W1427884753 countsByYear W14278847532015 @default.
• W1427884753 countsByYear W14278847532017 @default.
• W1427884753 countsByYear W14278847532018 @default.
• W1427884753 countsByYear W14278847532019 @default.
• W1427884753 countsByYear W14278847532020 @default.
• W1427884753 crossrefType "journal-article" @default.
• W1427884753 hasAuthorship W1427884753A5005583080 @default.
• W1427884753 hasAuthorship W1427884753A5008991847 @default.
• W1427884753 hasAuthorship W1427884753A5010448492 @default.
• W1427884753 hasAuthorship W1427884753A5016564415 @default.
• W1427884753 hasAuthorship W1427884753A5058128627 @default.
• W1427884753 hasAuthorship W1427884753A5058308987 @default.
• W1427884753 hasAuthorship W1427884753A5058932304 @default.
• W1427884753 hasAuthorship W1427884753A5073960839 @default.
• W1427884753 hasAuthorship W1427884753A5075845405 @default.
• W1427884753 hasAuthorship W1427884753A5086183706 @default.
• W1427884753 hasConcept C11772777 @default.
• W1427884753 hasConcept C126322002 @default.
• W1427884753 hasConcept C134018914 @default.
• W1427884753 hasConcept C140985366 @default.
• W1427884753 hasConcept C164705383 @default.
• W1427884753 hasConcept C171089720 @default.
• W1427884753 hasConcept C2778163477 @default.
• W1427884753 hasConcept C2778213512 @default.
• W1427884753 hasConcept C2778913445 @default.
• W1427884753 hasConcept C2780072125 @default.
• W1427884753 hasConcept C63363279 @default.
• W1427884753 hasConcept C71924100 @default.
• W1427884753 hasConcept C8243546 @default.
• W1427884753 hasConcept C90924648 @default.
• W1427884753 hasConceptScore W1427884753C11772777 @default.
• W1427884753 hasConceptScore W1427884753C126322002 @default.
• W1427884753 hasConceptScore W1427884753C134018914 @default.
• W1427884753 hasConceptScore W1427884753C140985366 @default.
• W1427884753 hasConceptScore W1427884753C164705383 @default.
• W1427884753 hasConceptScore W1427884753C171089720 @default.
• W1427884753 hasConceptScore W1427884753C2778163477 @default.
• W1427884753 hasConceptScore W1427884753C2778213512 @default.
• W1427884753 hasConceptScore W1427884753C2778913445 @default.
• W1427884753 hasConceptScore W1427884753C2780072125 @default.
• W1427884753 hasConceptScore W1427884753C63363279 @default.
• W1427884753 hasConceptScore W1427884753C71924100 @default.
• W1427884753 hasConceptScore W1427884753C8243546 @default.
• W1427884753 hasConceptScore W1427884753C90924648 @default.
• W1427884753 hasIssue "12" @default.
• W1427884753 hasLocation W14278847531 @default.
• W1427884753 hasLocation W14278847532 @default.
• W1427884753 hasOpenAccess W1427884753 @default.
• W1427884753 hasPrimaryLocation W14278847531 @default.
• W1427884753 hasRelatedWork W1517503165 @default.
• W1427884753 hasRelatedWork W1552938026 @default.

• next